New hope for pancreatic cancer? early trial combines novel drug with chemo
Disease control
Ongoing
This early-stage trial tests a new drug called OMO-103, given together with standard chemotherapy, in 26 people with advanced pancreatic cancer that has spread. The main goals are to check the safety of the combination and see if it helps shrink tumors. Participants must not have…
Phase: PHASE1 • Sponsor: Peptomyc S.L. • Aim: Disease control
Last updated May 22, 2026 14:02 UTC